Tae Hoon Yang

Title: Innovations of Tae Hoon Yang

Introduction

Tae Hoon Yang is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of engineered microorganisms. With a total of 4 patents, his work focuses on enhancing carbon flux efficiencies and metabolic pathways.

Latest Patents

One of his latest patents is titled "Methods and organisms with increased carbon flux efficiencies." This invention involves a non-naturally occurring microbial organism that features a first attenuation of a succinyl-CoA synthetase or transferase, along with a second attenuation of a succinyl-CoA converting enzyme. This multi-step pathway allows for the net conversion of succinyl-CoA to succinate. Another notable patent is "Engineered microorganisms with G3P → 3PG enzyme and/or fructose-1,6-bisphosphatase." This patent describes engineered cells that include an NADH-dependent enzyme capable of converting G3P to 3PG and/or fructose-1,6-bisphosphatase. These modifications enable the generation of C6 compounds from C1 and C5 compounds, enhancing the production of metabolic precursors for bioproduct pathways.

Career Highlights

Tae Hoon Yang is currently employed at Genomatica, Inc., where he continues to innovate in the field of synthetic biology. His work has been instrumental in advancing the understanding of metabolic engineering and its applications in sustainable bioproducts.

Collaborations

He collaborates with notable colleagues such as Anthony P. Burgard and Robin E. Osterhout, contributing to a dynamic research environment that fosters innovation.

Conclusion

Tae Hoon Yang's contributions to biotechnology through his patents and work at Genomatica, Inc. highlight his role as a leading inventor in the field. His innovative approaches to metabolic engineering are paving the way for sustainable solutions in bioproduct development.